APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Tropicamide

Compare research editions
View pricing & licenses

Selected research

Industry Research

Tropicamide Industry Research Report 2026

Report ID 174043380519 December 2025147 pages

Choose your research edition.

Industry ResearchTropicamide Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal Tropicamide Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Tropicamide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Tropicamide Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Tropicamide Market Analysis and Forecast 2026-2032208 pages · $4,950 USD

Market perspective

The global Tropicamide market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Tropicamide is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Tropicamide is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Tropicamide is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Tropicamide include Novartis, Watson Laboratories, Wakamoto, Visufarma, Vega Pharma, Unimed Pharma, Thea Pharma, Roemmers and Polfa Warszawa, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Tropicamide market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Tropicamide Market by Company

Novartis

Watson Laboratories

Wakamoto

Visufarma

Vega Pharma

Unimed Pharma

Thea Pharma

Roemmers

Polfa Warszawa

Pharma Stulln

Nippon Tenganyaku Kenkyujo

Miza Pharmaceuticals

Laboratorios Sophia

Edol

Dioptic Pharmaceuticals

Chauvin Ankerpharm

Bausch Health

Alcon Laboratories

Akorn

Agepha Pharma

Tropicamide Segment by Type

5mg

10mg

Tropicamide Segment by Application

Hospital

Drug Store

Tropicamide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tropicamide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Tropicamide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tropicamide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Tropicamide manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Tropicamide by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Tropicamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Tropicamide Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Tropicamide Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Tropicamide Sales Market Share by Manufacturers (2021-2026) Table 8. Global Tropicamide Revenue of Manufacturers (2021-2026) Table 9. Global Tropicamide Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Tropicamide Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Tropicamide Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Tropicamide, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Tropicamide, Product Type & Application Table 14. Global Tropicamide Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Tropicamide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Novartis Company Information Table 19. Novartis Business Overview Table 20. Novartis Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Novartis Tropicamide Product Portfolio Table 22. Novartis Recent Developments Table 23. Watson Laboratories Company Information Table 24. Watson Laboratories Business Overview Table 25. Watson Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Watson Laboratories Tropicamide Product Portfolio Table 27. Watson Laboratories Recent Developments Table 28. Wakamoto Company Information Table 29. Wakamoto Business Overview Table 30. Wakamoto Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Wakamoto Tropicamide Product Portfolio Table 32. Wakamoto Recent Developments Table 33. Visufarma Company Information Table 34. Visufarma Business Overview Table 35. Visufarma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Visufarma Tropicamide Product Portfolio Table 37. Visufarma Recent Developments Table 38. Vega Pharma Company Information Table 39. Vega Pharma Business Overview Table 40. Vega Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Vega Pharma Tropicamide Product Portfolio Table 42. Vega Pharma Recent Developments Table 43. Unimed Pharma Company Information Table 44. Unimed Pharma Business Overview Table 45. Unimed Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Unimed Pharma Tropicamide Product Portfolio Table 47. Unimed Pharma Recent Developments Table 48. Thea Pharma Company Information Table 49. Thea Pharma Business Overview Table 50. Thea Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Thea Pharma Tropicamide Product Portfolio Table 52. Thea Pharma Recent Developments Table 53. Roemmers Company Information Table 54. Roemmers Business Overview Table 55. Roemmers Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Roemmers Tropicamide Product Portfolio Table 57. Roemmers Recent Developments Table 58. Polfa Warszawa Company Information Table 59. Polfa Warszawa Business Overview Table 60. Polfa Warszawa Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Polfa Warszawa Tropicamide Product Portfolio Table 62. Polfa Warszawa Recent Developments Table 63. Pharma Stulln Company Information Table 64. Pharma Stulln Business Overview Table 65. Pharma Stulln Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Pharma Stulln Tropicamide Product Portfolio Table 67. Pharma Stulln Recent Developments Table 68. Nippon Tenganyaku Kenkyujo Company Information Table 69. Nippon Tenganyaku Kenkyujo Business Overview Table 70. Nippon Tenganyaku Kenkyujo Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio Table 72. Nippon Tenganyaku Kenkyujo Recent Developments Table 73. Miza Pharmaceuticals Company Information Table 74. Miza Pharmaceuticals Business Overview Table 75. Miza Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Miza Pharmaceuticals Tropicamide Product Portfolio Table 77. Miza Pharmaceuticals Recent Developments Table 78. Laboratorios Sophia Company Information Table 79. Laboratorios Sophia Business Overview Table 80. Laboratorios Sophia Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Laboratorios Sophia Tropicamide Product Portfolio Table 82. Laboratorios Sophia Recent Developments Table 83. Edol Company Information Table 84. Edol Business Overview Table 85. Edol Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Edol Tropicamide Product Portfolio Table 87. Edol Recent Developments Table 88. Dioptic Pharmaceuticals Company Information Table 89. Dioptic Pharmaceuticals Business Overview Table 90. Dioptic Pharmaceuticals Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Dioptic Pharmaceuticals Tropicamide Product Portfolio Table 92. Dioptic Pharmaceuticals Recent Developments Table 93. Chauvin Ankerpharm Company Information Table 94. Chauvin Ankerpharm Business Overview Table 95. Chauvin Ankerpharm Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Chauvin Ankerpharm Tropicamide Product Portfolio Table 97. Chauvin Ankerpharm Recent Developments Table 98. Bausch Health Company Information Table 99. Bausch Health Business Overview Table 100. Bausch Health Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Bausch Health Tropicamide Product Portfolio Table 102. Bausch Health Recent Developments Table 103. Alcon Laboratories Company Information Table 104. Alcon Laboratories Business Overview Table 105. Alcon Laboratories Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Alcon Laboratories Tropicamide Product Portfolio Table 107. Alcon Laboratories Recent Developments Table 108. Akorn Company Information Table 109. Akorn Business Overview Table 110. Akorn Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Akorn Tropicamide Product Portfolio Table 112. Akorn Recent Developments Table 113. Agepha Pharma Company Information Table 114. Agepha Pharma Business Overview Table 115. Agepha Pharma Tropicamide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Agepha Pharma Tropicamide Product Portfolio Table 117. Agepha Pharma Recent Developments Table 118. Global Tropicamide Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 119. Global Tropicamide Sales by Region (2021-2026) & (K Units) Table 120. Global Tropicamide Sales Market Share by Region (2021-2026) Table 121. Global Tropicamide Sales by Region (2027-2032) & (K Units) Table 122. Global Tropicamide Sales Market Share by Region (2027-2032) Table 123. Global Tropicamide Revenue by Region (2021-2026) & (US$ Million) Table 124. Global Tropicamide Revenue Market Share by Region (2021-2026) Table 125. Global Tropicamide Revenue by Region (2027-2032) & (US$ Million) Table 126. Global Tropicamide Revenue Market Share by Region (2027-2032) Table 127. North America Tropicamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 128. North America Tropicamide Sales by Country (2021-2026) & (K Units) Table 129. North America Tropicamide Sales by Country (2027-2032) & (K Units) Table 130. North America Tropicamide Revenue by Country (2021-2026) & (US$ Million) Table 131. North America Tropicamide Revenue by Country (2027-2032) & (US$ Million) Table 132. Europe Tropicamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 133. Europe Tropicamide Sales by Country (2021-2026) & (K Units) Table 134. Europe Tropicamide Sales by Country (2027-2032) & (K Units) Table 135. Europe Tropicamide Revenue by Country (2021-2026) & (US$ Million) Table 136. Europe Tropicamide Revenue by Country (2027-2032) & (US$ Million) Table 137. Asia Pacific Tropicamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. Asia Pacific Tropicamide Sales by Country (2021-2026) & (K Units) Table 139. Asia Pacific Tropicamide Sales by Country (2027-2032) & (K Units) Table 140. Asia Pacific Tropicamide Revenue by Country (2021-2026) & (US$ Million) Table 141. Asia Pacific Tropicamide Revenue by Country (2027-2032) & (US$ Million) Table 142. South America Tropicamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. South America Tropicamide Sales by Country (2021-2026) & (K Units) Table 144. South America Tropicamide Sales by Country (2027-2032) & (K Units) Table 145. South America Tropicamide Revenue by Country (2021-2026) & (US$ Million) Table 146. South America Tropicamide Revenue by Country (2027-2032) & (US$ Million) Table 147. Middle East and Africa Tropicamide Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Middle East and Africa Tropicamide Sales by Country (2021-2026) & (K Units) Table 149. Middle East and Africa Tropicamide Sales by Country (2027-2032) & (K Units) Table 150. Middle East and Africa Tropicamide Revenue by Country (2021-2026) & (US$ Million) Table 151. Middle East and Africa Tropicamide Revenue by Country (2027-2032) & (US$ Million) Table 152. Global Tropicamide Sales by Type (2021-2026) & (K Units) Table 153. Global Tropicamide Sales by Type (2027-2032) & (K Units) Table 154. Global Tropicamide Sales Market Share by Type (2021-2026) Table 155. Global Tropicamide Sales Market Share by Type (2027-2032) Table 156. Global Tropicamide Revenue by Type (2021-2026) & (US$ Million) Table 157. Global Tropicamide Revenue by Type (2027-2032) & (US$ Million) Table 158. Global Tropicamide Revenue Market Share by Type (2021-2026) Table 159. Global Tropicamide Revenue Market Share by Type (2027-2032) Table 160. Global Tropicamide Price by Type (2021-2026) & (US$/Unit) Table 161. Global Tropicamide Price by Type (2027-2032) & (US$/Unit) Table 162. Global Tropicamide Sales by Application (2021-2026) & (K Units) Table 163. Global Tropicamide Sales by Application (2027-2032) & (K Units) Table 164. Global Tropicamide Sales Market Share by Application (2021-2026) Table 165. Global Tropicamide Sales Market Share by Application (2027-2032) Table 166. Global Tropicamide Revenue by Application (2021-2026) & (US$ Million) Table 167. Global Tropicamide Revenue by Application (2027-2032) & (US$ Million) Table 168. Global Tropicamide Revenue Market Share by Application (2021-2026) Table 169. Global Tropicamide Revenue Market Share by Application (2027-2032) Table 170. Global Tropicamide Price by Application (2021-2026) & (US$/Unit) Table 171. Global Tropicamide Price by Application (2027-2032) & (US$/Unit) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Tropicamide Distributors List Table 175. Tropicamide Customers List Table 176. Tropicamide Industry Trends Table 177. Tropicamide Industry Drivers Table 178. Tropicamide Industry Restraints Table 179. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Tropicamide Product Image Figure 5. Global Tropicamide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Tropicamide Market Size (2021-2032) & (US$ Million) Figure 7. Global Tropicamide Sales (2021-2032) & (K Units) Figure 8. Global Tropicamide Average Price (US$/Unit) & (2021-2032) Figure 9. 5mg Product Image Figure 10. 10mg Product Image Figure 11. Hospital Product Image Figure 12. Drug Store Product Image Figure 13. Global Tropicamide Revenue Share by Manufacturers in 2025 Figure 14. Global Manufacturers of Tropicamide, Manufacturing Sites & Headquarters Figure 15. Global Top 5 and 10 Tropicamide Players Market Share by Revenue in 2025 Figure 16. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Tropicamide Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 18. Global Tropicamide Sales by Region in 2025 Figure 19. Global Tropicamide Revenue by Region in 2025 Figure 20. North America Tropicamide Market Size by Country in 2025 Figure 21. North America Tropicamide Sales Market Share by Country (2021-2032) Figure 22. North America Tropicamide Revenue Market Share by Country (2021-2032) Figure 23. United States Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 24. Canada Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Europe Tropicamide Market Size by Country in 2025 Figure 26. Europe Tropicamide Sales Market Share by Country (2021-2032) Figure 27. Europe Tropicamide Revenue Market Share by Country (2021-2032) Figure 28. Germany Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. France Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. U.K. Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Italy Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. Netherlands Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Asia Pacific Tropicamide Market Size by Country in 2025 Figure 34. Asia Pacific Tropicamide Sales Market Share by Country (2021-2032) Figure 35. Asia Pacific Tropicamide Revenue Market Share by Country (2021-2032) Figure 36. China Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Japan Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. South Korea Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. India Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Australia Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. China Taiwan Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Southeast Asia Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Southeast Asia Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South America Tropicamide Market Size by Country in 2025 Figure 45. South America Tropicamide Sales Market Share by Country (2021-2032) Figure 46. South America Tropicamide Revenue Market Share by Country (2021-2032) Figure 47. Mexico Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Brazil Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Argentina Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Middle East and Africa Tropicamide Market Size by Country in 2025 Figure 51. Middle East and Africa Tropicamide Sales Market Share by Country (2021-2032) Figure 52. Middle East and Africa Tropicamide Revenue Market Share by Country (2021-2032) Figure 53. Turkey Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Saudi Arabia Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. UAE Tropicamide Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Global Tropicamide Sales Market Share by Type (2021-2032) Figure 57. Global Tropicamide Revenue Market Share by Type (2021-2032) Figure 58. Global Tropicamide Price (US$/Unit) by Type (2021-2032) Figure 59. Global Tropicamide Sales Market Share by Application (2021-2032) Figure 60. Global Tropicamide Revenue Market Share by Application (2021-2032) Figure 61. Global Tropicamide Price (US$/Unit) by Application (2021-2032) Figure 62. Tropicamide Value Chain Figure 63. Tropicamide Production Mode & Process Figure 64. Direct Comparison with Distribution Share Figure 65. Distributors Profiles Figure 66. Tropicamide Industry Opportunities and Challenges

Scope & coverage.

Types
  • 5mg
  • 10mg
Applications
  • Hospital
  • Drug Store
Companies covered
  • Novartis
  • Watson Laboratories
  • Wakamoto
  • Visufarma
  • Vega Pharma
  • Unimed Pharma
  • Thea Pharma
  • Roemmers
  • Polfa Warszawa
  • Pharma Stulln
  • Nippon Tenganyaku Kenkyujo
  • Miza Pharmaceuticals
  • Laboratorios Sophia
  • Edol
  • Dioptic Pharmaceuticals
  • Chauvin Ankerpharm
  • Bausch Health
  • Alcon Laboratories
  • Akorn
  • Agepha Pharma

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Tropicamide Market Size (2021-2032)
  4. 2.2.2 Global Tropicamide Sales (2021-2032)
  5. 2.2.3 Global Tropicamide Market Average Price (2021-2032)
  6. 2.3 Tropicamide by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 5mg
  9. 2.3.3 10mg
  10. 2.4 Tropicamide by Application
  11. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  12. 2.4.2 Hospital
  13. 2.4.3 Drug Store
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Tropicamide Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Tropicamide Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Tropicamide Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Tropicamide Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Tropicamide Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Tropicamide, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Tropicamide, Product Type & Application
  8. 3.8 Global Manufacturers of Tropicamide, Established Date
  9. 3.9 Global Tropicamide Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Novartis
  2. 4.1.1 Novartis Company Information
  3. 4.1.2 Novartis Business Overview
  4. 4.1.3 Novartis Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Novartis Tropicamide Product Portfolio
  6. 4.1.5 Novartis Recent Developments
  7. 4.2 Watson Laboratories
  8. 4.2.1 Watson Laboratories Company Information
  9. 4.2.2 Watson Laboratories Business Overview
  10. 4.2.3 Watson Laboratories Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Watson Laboratories Tropicamide Product Portfolio
  12. 4.2.5 Watson Laboratories Recent Developments
  13. 4.3 Wakamoto
  14. 4.3.1 Wakamoto Company Information
  15. 4.3.2 Wakamoto Business Overview
  16. 4.3.3 Wakamoto Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Wakamoto Tropicamide Product Portfolio
  18. 4.3.5 Wakamoto Recent Developments
  19. 4.4 Visufarma
  20. 4.4.1 Visufarma Company Information
  21. 4.4.2 Visufarma Business Overview
  22. 4.4.3 Visufarma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Visufarma Tropicamide Product Portfolio
  24. 4.4.5 Visufarma Recent Developments
  25. 4.5 Vega Pharma
  26. 4.5.1 Vega Pharma Company Information
  27. 4.5.2 Vega Pharma Business Overview
  28. 4.5.3 Vega Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Vega Pharma Tropicamide Product Portfolio
  30. 4.5.5 Vega Pharma Recent Developments
  31. 4.6 Unimed Pharma
  32. 4.6.1 Unimed Pharma Company Information
  33. 4.6.2 Unimed Pharma Business Overview
  34. 4.6.3 Unimed Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Unimed Pharma Tropicamide Product Portfolio
  36. 4.6.5 Unimed Pharma Recent Developments
  37. 4.7 Thea Pharma
  38. 4.7.1 Thea Pharma Company Information
  39. 4.7.2 Thea Pharma Business Overview
  40. 4.7.3 Thea Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Thea Pharma Tropicamide Product Portfolio
  42. 4.7.5 Thea Pharma Recent Developments
  43. 4.8 Roemmers
  44. 4.8.1 Roemmers Company Information
  45. 4.8.2 Roemmers Business Overview
  46. 4.8.3 Roemmers Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Roemmers Tropicamide Product Portfolio
  48. 4.8.5 Roemmers Recent Developments
  49. 4.9 Polfa Warszawa
  50. 4.9.1 Polfa Warszawa Company Information
  51. 4.9.2 Polfa Warszawa Business Overview
  52. 4.9.3 Polfa Warszawa Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Polfa Warszawa Tropicamide Product Portfolio
  54. 4.9.5 Polfa Warszawa Recent Developments
  55. 4.10 Pharma Stulln
  56. 4.10.1 Pharma Stulln Company Information
  57. 4.10.2 Pharma Stulln Business Overview
  58. 4.10.3 Pharma Stulln Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Pharma Stulln Tropicamide Product Portfolio
  60. 4.10.5 Pharma Stulln Recent Developments
  61. 4.11 Nippon Tenganyaku Kenkyujo
  62. 4.11.1 Nippon Tenganyaku Kenkyujo Company Information
  63. 4.11.2 Nippon Tenganyaku Kenkyujo Business Overview
  64. 4.11.3 Nippon Tenganyaku Kenkyujo Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Nippon Tenganyaku Kenkyujo Tropicamide Product Portfolio
  66. 4.11.5 Nippon Tenganyaku Kenkyujo Recent Developments
  67. 4.12 Miza Pharmaceuticals
  68. 4.12.1 Miza Pharmaceuticals Company Information
  69. 4.12.2 Miza Pharmaceuticals Business Overview
  70. 4.12.3 Miza Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Miza Pharmaceuticals Tropicamide Product Portfolio
  72. 4.12.5 Miza Pharmaceuticals Recent Developments
  73. 4.13 Laboratorios Sophia
  74. 4.13.1 Laboratorios Sophia Company Information
  75. 4.13.2 Laboratorios Sophia Business Overview
  76. 4.13.3 Laboratorios Sophia Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Laboratorios Sophia Tropicamide Product Portfolio
  78. 4.13.5 Laboratorios Sophia Recent Developments
  79. 4.14 Edol
  80. 4.14.1 Edol Company Information
  81. 4.14.2 Edol Business Overview
  82. 4.14.3 Edol Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Edol Tropicamide Product Portfolio
  84. 4.14.5 Edol Recent Developments
  85. 4.15 Dioptic Pharmaceuticals
  86. 4.15.1 Dioptic Pharmaceuticals Company Information
  87. 4.15.2 Dioptic Pharmaceuticals Business Overview
  88. 4.15.3 Dioptic Pharmaceuticals Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Dioptic Pharmaceuticals Tropicamide Product Portfolio
  90. 4.15.5 Dioptic Pharmaceuticals Recent Developments
  91. 4.16 Chauvin Ankerpharm
  92. 4.16.1 Chauvin Ankerpharm Company Information
  93. 4.16.2 Chauvin Ankerpharm Business Overview
  94. 4.16.3 Chauvin Ankerpharm Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Chauvin Ankerpharm Tropicamide Product Portfolio
  96. 4.16.5 Chauvin Ankerpharm Recent Developments
  97. 4.17 Bausch Health
  98. 4.17.1 Bausch Health Company Information
  99. 4.17.2 Bausch Health Business Overview
  100. 4.17.3 Bausch Health Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Bausch Health Tropicamide Product Portfolio
  102. 4.17.5 Bausch Health Recent Developments
  103. 4.18 Alcon Laboratories
  104. 4.18.1 Alcon Laboratories Company Information
  105. 4.18.2 Alcon Laboratories Business Overview
  106. 4.18.3 Alcon Laboratories Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Alcon Laboratories Tropicamide Product Portfolio
  108. 4.18.5 Alcon Laboratories Recent Developments
  109. 4.19 Akorn
  110. 4.19.1 Akorn Company Information
  111. 4.19.2 Akorn Business Overview
  112. 4.19.3 Akorn Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Akorn Tropicamide Product Portfolio
  114. 4.19.5 Akorn Recent Developments
  115. 4.20 Agepha Pharma
  116. 4.20.1 Agepha Pharma Company Information
  117. 4.20.2 Agepha Pharma Business Overview
  118. 4.20.3 Agepha Pharma Tropicamide Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Agepha Pharma Tropicamide Product Portfolio
  120. 4.20.5 Agepha Pharma Recent Developments
5 Global Tropicamide Market Scenario by Region
  1. 5.1 Global Tropicamide Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Tropicamide Sales by Region: 2021-2032
  3. 5.2.1 Global Tropicamide Sales by Region: 2021-2026
  4. 5.2.2 Global Tropicamide Sales by Region: 2027-2032
  5. 5.3 Global Tropicamide Revenue by Region: 2021-2032
  6. 5.3.1 Global Tropicamide Revenue by Region: 2021-2026
  7. 5.3.2 Global Tropicamide Revenue by Region: 2027-2032
  8. 5.4 North America Tropicamide Market Facts & Figures by Country
  9. 5.4.1 North America Tropicamide Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Tropicamide Sales by Country (2021-2032)
  11. 5.4.3 North America Tropicamide Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Tropicamide Market Facts & Figures by Country
  15. 5.5.1 Europe Tropicamide Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Tropicamide Sales by Country (2021-2032)
  17. 5.5.3 Europe Tropicamide Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Tropicamide Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Tropicamide Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Tropicamide Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Tropicamide Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Tropicamide Market Facts & Figures by Country
  35. 5.7.1 South America Tropicamide Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Tropicamide Sales by Country (2021-2032)
  37. 5.7.3 South America Tropicamide Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Tropicamide Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Tropicamide Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Tropicamide Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Tropicamide Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Tropicamide Sales by Type (2021-2032)
  2. 6.1.1 Global Tropicamide Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Tropicamide Sales Market Share by Type (2021-2032)
  4. 6.2 Global Tropicamide Revenue by Type (2021-2032)
  5. 6.2.1 Global Tropicamide Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Tropicamide Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Tropicamide Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Tropicamide Sales by Application (2021-2032)
  2. 7.1.1 Global Tropicamide Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Tropicamide Sales Market Share by Application (2021-2032)
  4. 7.2 Global Tropicamide Revenue by Application (2021-2032)
  5. 7.2.1 Global Tropicamide Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Tropicamide Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Tropicamide Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Tropicamide Value Chain Analysis
  2. 8.1.1 Tropicamide Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Tropicamide Production Mode & Process
  5. 8.2 Tropicamide Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Tropicamide Distributors
  8. 8.2.3 Tropicamide Customers
9 Global Tropicamide Analyzing Market Dynamics
  1. 9.1 Tropicamide Industry Trends
  2. 9.2 Tropicamide Industry Drivers
  3. 9.3 Tropicamide Industry Opportunities and Challenges
  4. 9.4 Tropicamide Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research, Inc.
      Talk to an analyst